Given that regulatory cells constitute an important source of IL-10, we thought that serum IL-10 levels in DM patients might be significantly lower than those in healthy controls, considering that Bregs are remarkably reduced in DM patients. This evidence concerns the gene IL10 and dermatomyositis.